Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 2 | 808 | 122 | 0.6736 | 0.6759 | 0.1510 | 0.1363 |
COLO 858 | Vemurafenib | Defactinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 809 | 781 | 0.0033 | 0.0047 | 0.9654 | 0.9535 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 3 | 810 | 688 | 0.0207 | 0.0199 | 0.8494 | 0.8770 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 1 | 811 | 41 | 0.7796 | 0.6166 | 0.0506 | 0.0527 |
MMAC-SF | Vemurafenib | Defactinib | 3.160 | 0.000 | uM | 72 | hr | 3 | 816 | 378 | 0.2699 | 0.2403 | 0.4632 | 0.4433 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 3 | 817 | 651 | 0.0275 | 0.0307 | 0.7968 | 0.7891 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 818 | 40 | 0.7640 | 0.6789 | 0.0489 | 0.0471 |
MMAC-SF | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 819 | 228 | 0.4715 | 0.3311 | 0.2784 | 0.2885 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 2 | 820 | 119 | 0.5593 | 0.5335 | 0.1451 | 0.1422 |
MZ7-mel | Vemurafenib | Dasatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 820 | 65 | 0.1518 | 0.1839 | 0.0793 | 0.0837 |
MMAC-SF | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 823 | 140 | 0.5449 | 0.4894 | 0.1701 | 0.1367 |
MMAC-SF | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 826 | 215 | 0.3765 | 0.3619 | 0.2603 | 0.2613 |
MMAC-SF | Vemurafenib | Defactinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 828 | 289 | 0.3321 | 0.2820 | 0.3490 | 0.3755 |
COLO 858 | Vemurafenib | Belinostat | 0.000 | 1.000 | uM | 72 | hr | 3 | 831 | 298 | 0.1223 | 0.1295 | 0.3586 | 0.3690 |
MZ7-mel | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 832 | 108 | 0.2361 | 0.2764 | 0.1298 | 0.1279 |
MMAC-SF | Vemurafenib | PF562271 | 0.316 | 0.000 | uM | 72 | hr | 2 | 832 | 118 | 0.7229 | 0.6679 | 0.1418 | 0.1517 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 0.316 | uM | 72 | hr | 2 | 832 | 414 | 0.0693 | 0.0722 | 0.4976 | 0.5757 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 1.000 | uM | 72 | hr | 2 | 832 | 777 | 0.0099 | 0.0092 | 0.9339 | 0.9423 |
COLO 858 | Vemurafenib | PF562271 | 3.160 | 0.316 | uM | 72 | hr | 3 | 833 | 776 | 0.0103 | 0.0125 | 0.9316 | 0.9029 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 1.000 | uM | 72 | hr | 2 | 833 | 687 | 0.0263 | 0.0248 | 0.8247 | 0.8407 |
COLO 858 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 3 | 835 | 731 | 0.0176 | 0.0171 | 0.8754 | 0.8905 |
MMAC-SF | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 837 | 30 | 0.4972 | 0.4909 | 0.0358 | 0.0363 |
MZ7-mel | Vemurafenib | Defactinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 837 | 184 | 0.1435 | 0.1699 | 0.2198 | 0.2362 |
MZ7-mel | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 839 | 282 | 0.1817 | 0.3021 | 0.3361 | 0.3372 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 2 | 839 | 656 | 0.0303 | 0.0307 | 0.7819 | 0.7891 |